Company intelligence / Profile preview

KLP

Norway

Ownership: Private
Development stage: Other

Overview

KLP refers to multiple entities: Kommunal Landspensjonskasse (Norway's largest public-sector pension provider offering pensions, banking, asset management, and insurance); KLP Enterprises (an entrepreneurial investor group/trust focusing on biotechnology, medical equipment, healthcare, clean technology, software, and real-estate investments); and KLP LLC (a U.S. community retail pharmacy). None are operating biotech/biopharma product companies, with KLP Enterprises being a healthcare/biotech investor.

Industry: Investors

Beyond the preview

Go deeper on KLP.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KLP.

Explore the full profile